These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 30764707)

  • 1. The great escape: How metastases of melanoma, and other carcinomas, avoid elimination.
    Wells A; Clark A; Bradshaw A; Ma B; Edington H
    Exp Biol Med (Maywood); 2018 Dec; 243(17-18):1245-1255. PubMed ID: 30764707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Influence of Tumor Microenvironment on Immune Escape of Melanoma.
    Simiczyjew A; Dratkiewicz E; Mazurkiewicz J; Ziętek M; Matkowski R; Nowak D
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33171792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Melanoma therapeutic escape: the biomechanical track].
    Lecacheur M; Girard CA; Deckert M; Tartare-Deckert S
    Med Sci (Paris); 2020 Nov; 36(11):961-965. PubMed ID: 33151853
    [No Abstract]   [Full Text] [Related]  

  • 4. Melanoma-induced immunosuppression and its neutralization.
    Umansky V; Sevko A
    Semin Cancer Biol; 2012 Aug; 22(4):319-26. PubMed ID: 22349515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary and Acquired Resistance to Immune Checkpoint Inhibitors in Metastatic Melanoma.
    Gide TN; Wilmott JS; Scolyer RA; Long GV
    Clin Cancer Res; 2018 Mar; 24(6):1260-1270. PubMed ID: 29127120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressive cells in tumor immune escape and metastasis.
    Liu Y; Cao X
    J Mol Med (Berl); 2016 May; 94(5):509-22. PubMed ID: 26689709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unraveling the crosstalk between melanoma and immune cells in the tumor microenvironment.
    Marzagalli M; Ebelt ND; Manuel ER
    Semin Cancer Biol; 2019 Dec; 59():236-250. PubMed ID: 31404607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic strategies of melanoma cells: Mechanisms, interactions with the tumor microenvironment, and therapeutic implications.
    Fischer GM; Vashisht Gopal YN; McQuade JL; Peng W; DeBerardinis RJ; Davies MA
    Pigment Cell Melanoma Res; 2018 Jan; 31(1):11-30. PubMed ID: 29049843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNF Receptor-2 Facilitates an Immunosuppressive Microenvironment in the Liver to Promote the Colonization and Growth of Hepatic Metastases.
    Ham B; Wang N; D'Costa Z; Fernandez MC; Bourdeau F; Auguste P; Illemann M; Eefsen RL; Høyer-Hansen G; Vainer B; Evrard M; Gao ZH; Brodt P
    Cancer Res; 2015 Dec; 75(24):5235-47. PubMed ID: 26483205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of Metastasis by NK Cells.
    López-Soto A; Gonzalez S; Smyth MJ; Galluzzi L
    Cancer Cell; 2017 Aug; 32(2):135-154. PubMed ID: 28810142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microenvironmental Regulation of Tumor Progression and Therapeutic Response in Brain Metastasis.
    Schulz M; Salamero-Boix A; Niesel K; Alekseeva T; Sevenich L
    Front Immunol; 2019; 10():1713. PubMed ID: 31396225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic tumour cell plasticity as a resistance mechanism and therapeutic target in melanoma.
    Roesch A; Paschen A; Landsberg J; Helfrich I; Becker JC; Schadendorf D
    Eur J Cancer; 2016 May; 59():109-112. PubMed ID: 27023049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-146a Controls Immune Response in the Melanoma Microenvironment.
    Mastroianni J; Stickel N; Andrlova H; Hanke K; Melchinger W; Duquesne S; Schmidt D; Falk M; Andrieux G; Pfeifer D; Dierbach H; Schmitt-Graeff A; Meiss F; Boerries M; Zeiser R
    Cancer Res; 2019 Jan; 79(1):183-195. PubMed ID: 30425059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.
    Ascierto PA; Agarwala S; Botti G; Cesano A; Ciliberto G; Davies MA; Demaria S; Dummer R; Eggermont AM; Ferrone S; Fu YX; Gajewski TF; Garbe C; Huber V; Khleif S; Krauthammer M; Lo RS; Masucci G; Palmieri G; Postow M; Puzanov I; Silk A; Spranger S; Stroncek DF; Tarhini A; Taube JM; Testori A; Wang E; Wargo JA; Yee C; Zarour H; Zitvogel L; Fox BA; Mozzillo N; Marincola FM; Thurin M
    J Transl Med; 2016 Nov; 14(1):313. PubMed ID: 27846884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockout of MDA-9/Syntenin (SDCBP) expression in the microenvironment dampens tumor-supporting inflammation and inhibits melanoma metastasis.
    Das SK; Guo C; Pradhan AK; Bhoopathi P; Talukdar S; Shen XN; Emdad L; Subler MA; Windle JJ; Sarkar D; Wang XY; Fisher PB
    Oncotarget; 2016 Jul; 7(30):46848-46861. PubMed ID: 27341128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel and enhanced anti-melanoma DNA vaccine targeting the tyrosinase protein inhibits myeloid-derived suppressor cells and tumor growth in a syngeneic prophylactic and therapeutic murine model.
    Yan J; Tingey C; Lyde R; Gorham TC; Choo DK; Muthumani A; Myles D; Weiner LP; Kraynyak KA; Reuschel EL; Finkel TH; Kim JJ; Sardesai NY; Ugen KE; Muthumani K; Weiner DB
    Cancer Gene Ther; 2014 Dec; 21(12):507-17. PubMed ID: 25394503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver metastases: Microenvironments and ex-vivo models.
    Clark AM; Ma B; Taylor DL; Griffith L; Wells A
    Exp Biol Med (Maywood); 2016 Sep; 241(15):1639-52. PubMed ID: 27390264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The metabolic milieu in melanoma: Role of immune suppression by CD73/adenosine.
    Passarelli A; Tucci M; Mannavola F; Felici C; Silvestris F
    Tumour Biol; 2019 Apr; 42(4):1010428319837138. PubMed ID: 30957676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of MHC class I molecules in anti-tumoral mechanisms in human malignant melanoma].
    Dissemond J; Grabbe S
    Hautarzt; 2006 Aug; 57(8):690-6. PubMed ID: 16163561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloid-derived suppressor cells in malignant melanoma.
    Umansky V; Sevko A; Gebhardt C; Utikal J
    J Dtsch Dermatol Ges; 2014 Nov; 12(11):1021-7. PubMed ID: 25263083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.